<DOC>
	<DOCNO>NCT00279773</DOCNO>
	<brief_summary>The primary objective determine maximum tolerate dose ( MTD ) , dose limit toxicity ( DLT ) , safety profile TKI258 administer subject acute myeloid leukemia ( AML ) .</brief_summary>
	<brief_title>Safety , Pharmacokinetics Pharmacodynamics TKI258 Subjects With Acute Myeloid Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Confirmed diagnosis Acute Myeloid Leukemia Eighteen year age old Life expectancy least 2 month Intracranial disease epidural disease Clinically significant cardiac disease Diabetes mellitus uncontrolled medication Pregnant breast feed woman Dementia alter mental status Known preexist clinically significant uncontrolled disorder hypothalamicpituitary axis , adrenal thyroid glands Previous pericarditis Malabsorption syndrome uncontrolled gastrointestinal symptom nausea , diarrhea , vomit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Acute</keyword>
	<keyword>Myeloid</keyword>
	<keyword>Leukemia</keyword>
</DOC>